Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

CVS Health Survey Reveals Smoking Trends Among Young Adults

  • The Pharma Data
  • May 24, 2025

Rethinking Nicotine: CVS Health Survey Uncovers Widespread Misconceptions About E-Cigarette Safety Among Young Adults Over the past few decades, the public conversation around tobacco and nicotine use has transformed dramatically.…

Read MoreCVS Health Survey Reveals Smoking Trends Among Young Adults
  • News

ASCENT-03: Trodelvy Significantly Improves PFS in First-Line mTNBC Patients Ineligible for Checkpoint Inhibitors

  • The Pharma Data
  • May 24, 2025

Trodelvy Marks Breakthrough in First-Line mTNBC Treatment with Positive Phase 3 ASCENT-03 Results Gilead Sciences has announced encouraging topline results from its Phase 3 ASCENT-03 clinical trial evaluating Trodelvy® (sacituzumab…

Read MoreASCENT-03: Trodelvy Significantly Improves PFS in First-Line mTNBC Patients Ineligible for Checkpoint Inhibitors
  • Press Releases

Bayer Launches Centafore Imaging Core Lab for Clinical Trials and SaMD Development

  • The Pharma Data
  • May 23, 2025

Bayer Launches Centafore Imaging Core Lab to Revolutionize Clinical Trial Imaging and SaMD Development Bayer, a global leader in healthcare and life sciences, today officially announced the launch of its…

Read MoreBayer Launches Centafore Imaging Core Lab for Clinical Trials and SaMD Development
  • Research

Merck Highlights Cutting-Edge Advances in Treating Advanced Cancers and Rare Tumors at ASCO 2025

  • The Pharma Data
  • May 23, 2025

Merck Highlights Breakthrough Innovations in Advanced Cancers and Rare Tumors at ASCO 2025 Merck, a global leader in science and technology, has once again showcased its commitment to transforming cancer…

Read MoreMerck Highlights Cutting-Edge Advances in Treating Advanced Cancers and Rare Tumors at ASCO 2025
  • News

US FDA Grants Approval for Nucala (Mepolizumab) to Treat Adults with Chronic Obstructive Pulmonary Disease (COPD)

  • The Pharma Data
  • May 23, 2025

GSK’s Nucala (Mepolizumab) Receives US FDA Approval as Add-On Maintenance Treatment for Adults with Eosinophilic Phenotype COPD GSK has officially announced a significant milestone in the treatment of chronic obstructive…

Read MoreUS FDA Grants Approval for Nucala (Mepolizumab) to Treat Adults with Chronic Obstructive Pulmonary Disease (COPD)
Zoetis
  • Press Releases

Dr. Mark Stetter Joins Zoetis Board of Directors Following Election

  • The Pharma Data
  • May 23, 2025

Dr. Mark Stetter Elected to Zoetis Board of Directors, Bringing Decades of Veterinary Leadership and Animal Health Expertise Zoetis,a global leader in animal health, announced a significant addition to its…

Read MoreDr. Mark Stetter Joins Zoetis Board of Directors Following Election
  • News

Linvoseltamab Combos Show Early Promise in Relapsed/Refractory Multiple Myeloma

  • The Pharma Data
  • May 23, 2025

Regeneron’s Linvoseltamab Combinations Show Strong Early Signals in Relapsed/Refractory Multiple Myeloma in Phase 1b Trial Regeneron Pharmaceuticals,has reported encouraging early findings from the ongoing Phase 1b LINKER-MM2 study, evaluating linvoseltamab…

Read MoreLinvoseltamab Combos Show Early Promise in Relapsed/Refractory Multiple Myeloma
  • Press Releases

Bristol Myers Squibb to Showcase Oncology Pipeline and Research at ASCO 2025

  • The Pharma Data
  • May 23, 2025

Bristol Myers Squibb Showcases Expansive Oncology Portfolio and Groundbreaking Clinical Research at ASCO 2025 Annual Meeting Bristol Myers Squibb is set to make a significant impact at the 2025 American…

Read MoreBristol Myers Squibb to Showcase Oncology Pipeline and Research at ASCO 2025
  • News

XTANDI Demonstrates Long-Term Survival in Metastatic Prostate Cancer

  • The Pharma Data
  • May 23, 2025

XTANDI Delivers Sustained Five-Year Survival Benefit in Metastatic Hormone-Sensitive Prostate Cancer: Landmark Findings from ARCHES and ENZAMET Trials Presented at ASCO 2025 Astellas Pharma Inc. and Pfizer Inc. have announced…

Read MoreXTANDI Demonstrates Long-Term Survival in Metastatic Prostate Cancer
  • News

FDA Grants Approval to Roche’s Susvimo for Treatment of Diabetic Retinopathy

  • The Pharma Data
  • May 23, 2025

FDA Approves Roche’s Susvimo as the First and Only Continuous-Delivery Treatment for Diabetic Retinopathy, Offering Nine-Month Dosing Durability In a significant advancement for patients suffering from diabetic retinopathy (DR), the…

Read MoreFDA Grants Approval to Roche’s Susvimo for Treatment of Diabetic Retinopathy
  • Press Releases

Lilly’s Kisunla Approved in Australia for Early Alzheimer’s Treatment

  • The Pharma Data
  • May 22, 2025

Lilly’s Kisunla (Donanemab) Gains Marketing Authorization in Australia for Early Alzheimer’s Treatment Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for…

Read MoreLilly’s Kisunla Approved in Australia for Early Alzheimer’s Treatment
  • News

Addressing Barriers: An Open Letter on Obesity Care and Insurance Access

  • The Pharma Data
  • May 22, 2025

A Call for Change: Ensuring Access and Insurance Coverage for People Living with Obesity In recent months, abrupt changes to insurance coverage for obesity management medications have placed thousands of…

Read MoreAddressing Barriers: An Open Letter on Obesity Care and Insurance Access
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Novartis to Acquire Excellergy, Inc., Strengthening Allergy Leadership with Next-Generation Anti-IgE Innovation
  • AbbVie to Present New Data Advancing Care in Immune-Mediated Skin Diseases at AAD 2026
  • Eli Lilly and Company’s EBGLYSS Shows Up to Four Years of Sustained Control in Atopic Dermatitis
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.